INVIRASE Side Effects

6723885-2 | Alpha 1 Foetoprotein Increased, Laboratory Test Abnormal, Normal Newborn
on Mar 05, 2010 Male patient from UNITED KINGDOM , weighting 5.95 lb, was treated with Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: alpha 1 foetoprotein increased, laboratory test abnormal, normal newborn. Invirase dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EPZICOM (View Epzicom Review and Epzicom Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6723834-7 | Alpha 1 Foetoprotein Increased, Laboratory Test Abnormal, Normal Newborn
Patient was taking Invirase (View Usage). Patient had the following side effects: alpha 1 foetoprotein increased, laboratory test abnormal, normal newborn on Mar 05, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 5.95 lb, . Invirase dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EPZICOM (View Epzicom Review and Epzicom Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6691993-0 | Alpha 1 Foetoprotein Abnormal, Alpha 1 Foetoprotein Increased, Normal Newborn
Adverse event was reported on Apr 09, 2010 by a Male patient taking Invirase (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), antiviral treatment and. Location: UNITED KINGDOM , weighting 5.95 lb, After Invirase was administered, patient had the following side effects: alpha 1 foetoprotein abnormal, alpha 1 foetoprotein increased, normal newborn. During the same period patient was treated with COMBIVIR (Dose Reported 2df) (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), KIVEXA (View Kivexa Review and Kivexa Label ).

6604811-3 | Convulsion, Dialysis
on Feb 19, 2010 Male patient from UNITED STATES , weighting 140.0 lb, was treated with Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, dialysis (What is dialysis?). Invirase dosage: Frequency: Daily. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), DEPAKOTE (View Depakote Review and Depakote Label ).


6596168-1 | Alpha 1 Foetoprotein Increased, Normal Newborn
on Feb 12, 2010 Male patient from UNITED KINGDOM , weighting 5.95 lb, was diagnosed with hiv infection (What is hiv infection?), antiviral treatment and was treated with Invirase (View Usage). Patient had the following side effects: alpha 1 foetoprotein increased, normal newborn. Invirase dosage: . During the same period patient was treated with COMBIVIR (Dose Reported 2df) (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), KIVEXA (View Kivexa Review and Kivexa Label ).

6574141-7 | Neuroendocrine Carcinoma Of The Skin
Patient was taking Invirase (View Usage). After Invirase was administered, patient had the following side effects: neuroendocrine carcinoma of the skin on Oct 12, 2009 from ITALY Additional patient health information: Male patient , 66 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Invirase dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), PROLEUKIN (View Proleukin Review and Proleukin Label ).

6490025-7 | Alpha 1 Foetoprotein Increased
Adverse event was reported on Dec 07, 2009 by a Female patient taking Invirase (View Usage) (Dosage: Form Reported As Dry Tablet.) . Location: UNITED KINGDOM , weighting 5.95 lb, Patient experienced the following unwanted or unexpected effects: alpha 1 foetoprotein increased. During the same period patient was treated with KIVEXA (Started Prior To Conception. Dosing Regimen: Daily.) (View Kivexa Review and Kivexa Label ), LAMIVUDINE (Started Prior To Conception) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (Started Prior To Conception.) (View Nevirapine Review and Nevirapine Label ), NORVIR (View Norvir Review and Norvir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6466296-X | Alpha 1 Foetoprotein Increased, Normal Newborn
on Nov 20, 2009 Male patient from UNITED KINGDOM , weighting 5.95 lb, was diagnosed with hiv infection (What is hiv infection?), antiviral treatment and was treated with Invirase (View Usage). Patient had the following side effects: alpha 1 foetoprotein increased, normal newborn. Invirase dosage: . During the same period patient was treated with COMBIVIR (Dose Reported 2df) (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), KIVEXA (View Kivexa Review and Kivexa Label ).

6461949-1 | Alpha 1 Foetoprotein Increased, Laboratory Test Abnormal, Normal Newborn
on Nov 20, 2009 Male patient from UNITED KINGDOM , weighting 5.95 lb, was treated with Invirase (View Usage). After Invirase was administered, patient had the following side effects: alpha 1 foetoprotein increased, laboratory test abnormal, normal newborn. Invirase dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EPZICOM (View Epzicom Review and Epzicom Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6461948-X | Alpha 1 Foetoprotein Increased, Normal Newborn
Patient was taking Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: alpha 1 foetoprotein increased, normal newborn on Nov 20, 2009 from UNITED KINGDOM Additional patient health information: Male patient , weighting 5.95 lb, was diagnosed with hiv infection (What is hiv infection?), antiviral treatment and. Invirase dosage: . During the same period patient was treated with COMBIVIR (Dose Reported 2df) (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), KIVEXA (View Kivexa Review and Kivexa Label ).

6460437-6 | Fanconi Syndrome, Glycosuria, Hypokalaemia, Hypophosphataemia, Nephrocalcinosis, Proteinuria, Renal Failure Chronic
Adverse event was reported on Nov 16, 2009 by a Male patient taking Invirase (View Usage) (Dosage: ) . Location: SWITZERLAND , 61 years of age, weighting 88.18 lb, Patient had the following side effects: fanconi syndrome, glycosuria, hypokalaemia, hypophosphataemia, nephrocalcinosis, proteinuria, renal failure chronic. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), TRUVADA (View Truvada Review and Truvada Label ), REYATAZ (View Reyataz Review and Reyataz Label ), NORVIR (View Norvir Review and Norvir Label ), 3TC (View 3tc Review and 3tc Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), STOCRIN (View Stocrin Review and Stocrin Label ). Patient was hospitalized.

6427927-3 | Alpha 1 Foetoprotein Increased, Laboratory Test Abnormal, Normal Newborn
on Oct 22, 2009 Male patient from UNITED KINGDOM , weighting 5.95 lb, was treated with Invirase (View Usage). After Invirase was administered, patient had the following side effects: alpha 1 foetoprotein increased, laboratory test abnormal, normal newborn. Invirase dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EPZICOM (View Epzicom Review and Epzicom Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6407087-5 | Congenital Anomaly, Normal Newborn
on Oct 07, 2009 Male patient from UNITED KINGDOM , weighting 5.95 lb, was diagnosed with hiv infection (What is hiv infection?), antiviral treatment and was treated with Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: congenital anomaly, normal newborn. Invirase dosage: . During the same period patient was treated with COMBIVIR (Dose Reported 2df) (View Combivir Review and Combivir Label ), EPZICOM (Dose Reported 1df) (View Epzicom Review and Epzicom Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ).

6406858-9 | Alpha 1 Foetoprotein Increased, Laboratory Test Abnormal, Normal Newborn
Patient was taking Invirase (View Usage). Patient had the following side effects: alpha 1 foetoprotein increased, laboratory test abnormal, normal newborn on Oct 07, 2009 from UNITED KINGDOM Additional patient health information: Male patient , weighting 5.95 lb, . Invirase dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EPZICOM (View Epzicom Review and Epzicom Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6389714-4 | Alpha 1 Foetoprotein Abnormal, Normal Newborn
Adverse event was reported on Sep 23, 2009 by a Male patient taking Invirase (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , weighting 5.95 lb, After Invirase was administered, patient had the following side effects: alpha 1 foetoprotein abnormal, normal newborn. During the same period patient was treated with COMBIVIR (Dose Reported 2df) (View Combivir Review and Combivir Label ), EPZICOM (Dose Reported 1df) (View Epzicom Review and Epzicom Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6376632-0 | Alpha 1 Foetoprotein Increased
on Sep 14, 2009 Female patient from UNITED KINGDOM , weighting 5.95 lb, was treated with Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: alpha 1 foetoprotein increased. Invirase dosage: Form Reported As Dry Tablet.. During the same period patient was treated with KIVEXA (Started Prior To Conception. Dosing Regimen: Daily.) (View Kivexa Review and Kivexa Label ), LAMIVUDINE (Started Prior To Conception) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (Started Prior To Conception.) (View Nevirapine Review and Nevirapine Label ), NORVIR (View Norvir Review and Norvir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6228926-7 | Bacterial Infection, Blood Glucose Increased, Clostridium Difficile Colitis, Diabetes Mellitus, Diarrhoea, Hiv Test Positive, Hypercholesterolaemia, Hypertriglyceridaemia, Lipodystrophy Acquired
on Jun 03, 2009 Male patient from CANADA , 37 years of age, was treated with Invirase (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), blood glucose increased, clostridium difficile colitis, diabetes mellitus, diarrhoea, hiv test positive (What is hiv test positive?), hypercholesterolaemia, hypertriglyceridaemia, lipodystrophy acquired. Invirase dosage: Dose: Hard Gel Capsule. During the same period patient was treated with FORTOVASE (Form: Hard Gel Capsule) (View Fortovase Review and Fortovase Label ), VIRAMUNE (View Viramune Review and Viramune Label ), ZERIT (View Zerit Review and Zerit Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NORVIR (View Norvir Review and Norvir Label ).

6228897-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatotoxicity
Patient was taking Invirase (View Usage). After Invirase was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatotoxicity on Jun 03, 2009 from CANADA Additional patient health information: Male patient , 29 years of age, . Invirase dosage: Dose Duration: 5 Months. During the same period patient was treated with LAMIVUDINE (Dose Duration: 5 Months) (View Lamivudine Review and Lamivudine Label ), RITONAVIR (Dose Duration: 5 Months) (View Ritonavir Review and Ritonavir Label ), STAVUDINE (Dose Duration: 5 Months) (View Stavudine Review and Stavudine Label ).

6173654-X | Foetal Macrosomia, Normal Newborn
Adverse event was reported on Apr 10, 2009 by a Male patient taking Invirase (View Usage) (Dosage: Frequency Reported As Qd) was diagnosed with hiv infection (What is hiv infection?), anaemia prophylaxis and. Location: FRANCE , weighting 11.02 lb, Patient experienced the following unwanted or unexpected effects: foetal macrosomia, normal newborn. During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

6171835-2 | Foetal Macrosomia, Normal Newborn
on Apr 10, 2009 Male patient from FRANCE , weighting 11.02 lb, was diagnosed with hiv infection (What is hiv infection?), anaemia prophylaxis and was treated with Invirase (View Usage). Patient had the following side effects: foetal macrosomia, normal newborn. Invirase dosage: Frequency Reported As Qd. During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

6085294-1 | Bone Tuberculosis, Haematuria, Mycobacterial Infection, Tuberculous Abscess Central Nervous System
on Jun 17, 2008 Male patient from UNITED STATES , 26 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Invirase (View Usage). After Invirase was administered, patient had the following side effects: bone tuberculosis, haematuria, mycobacterial infection, tuberculous abscess central nervous system. Invirase dosage: 2 Per Day. Patient was hospitalized.

6011511-X | Cachexia, Dyspnoea, Hypertension, Left Ventricular Dysfunction, Myocarditis, Pyrexia, Renal Failure
Patient was taking Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: cachexia, dyspnoea, hypertension, left ventricular dysfunction, myocarditis, pyrexia, renal failure on Dec 12, 1997 from FRANCE Additional patient health information: Male patient , weighting 121.3 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis, mycobacterium avium complex infection and. Invirase dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LITHIUM (View Lithium Review and Lithium Label ), DEPAMIDE (View Depamide Review and Depamide Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), EPIVIR (View Epivir Review and Epivir Label ). Patient was hospitalized.

5941701-3 | Foetal Macrosomia, Normal Newborn
Adverse event was reported on Oct 23, 2008 by a Male patient taking Invirase (View Usage) (Dosage: Frequency Reported As Qd) was diagnosed with hiv infection (What is hiv infection?), anaemia prophylaxis and. Location: FRANCE , weighting 11.02 lb, Patient had the following side effects: foetal macrosomia, normal newborn. During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ).

5914781-9 | Abortion Spontaneous, Complication Of Pregnancy
on Sep 29, 2008 Female patient from UNITED STATES , 23 years of age, weighting 270.9 lb, was diagnosed with acute hiv infection (What is acute hiv infection?) and was treated with Invirase (View Usage). After Invirase was administered, patient had the following side effects: abortion spontaneous, complication of pregnancy. Invirase dosage: Indication Reported As: Asymptomatic Acute (primary) Hiv Or Pgl.. During the same period patient was treated with EPZICOM (Total Daily Dose: 600mg/300mg. Indication Reported As: Asymptomatic Acute (primary) Hiv Or Pgl.) (View Epzicom Review and Epzicom Label ).

5879858-5 | Cachexia, Cerebrovascular Disorder, Depression, Headache, Pancreatitis Chronic, Pneumocystis Jiroveci Pneumonia
on Sep 05, 2008 Male patient from UNITED STATES , 22 years of age, was treated with Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: cachexia, cerebrovascular disorder, depression (What is depression?), headache (What is headache?), pancreatitis chronic, pneumocystis jiroveci pneumonia. Invirase dosage: . During the same period patient was treated with NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

5844996-X | Gastrointestinal Haemorrhage, Jaundice
Patient was taking Invirase (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, jaundice (What is jaundice?) on Aug 06, 2008 from UNITED STATES Additional patient health information: Male patient , 52 years of age, . Invirase dosage: . Patient was hospitalized.

5842278-3 | Aspartate Aminotransferase Increased, Atrial Fibrillation, Blood Alkaline Phosphatase Increased, Hepatic Failure, Jaundice, Lactic Acidosis, Liver Function Test Abnormal, Nausea, Sepsis
Adverse event was reported on Jul 31, 2008 by a Male patient taking Invirase (View Usage) (Dosage: ) was diagnosed with cd4 lymphocytes decreased, hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , weighting 154.3 lb, After Invirase was administered, patient had the following side effects: aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), blood alkaline phosphatase increased, hepatic failure, jaundice (What is jaundice?), lactic acidosis, liver function test abnormal, nausea (What is nausea?), sepsis (What is sepsis?). During the same period patient was treated with CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ), STAVUDINE (Interval Reported As 1 Day) (View Stavudine Review and Stavudine Label ), DDI (Interval Reported As 1 Day) (View Ddi Review and Ddi Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), ZALCITABINE (Interval Reported As 1 Day) (View Zalcitabine Review and Zalcitabine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

5806215-X | Aspartate Aminotransferase Increased, Atrial Fibrillation, Blood Alkaline Phosphatase Increased, Hepatic Failure, Jaundice, Lactic Acidosis, Liver Function Test Abnormal, Nausea, Sepsis
on Jul 01, 2008 Male patient from UNITED KINGDOM , weighting 154.3 lb, was diagnosed with cd4 lymphocytes decreased, hiv infection (What is hiv infection?) and was treated with Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), blood alkaline phosphatase increased, hepatic failure, jaundice (What is jaundice?), lactic acidosis, liver function test abnormal, nausea (What is nausea?), sepsis (What is sepsis?). Invirase dosage: . During the same period patient was treated with CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ), D4T (View D4t Review and D4t Label ), DDI (View Ddi Review and Ddi Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), ZALCITABINE (View Zalcitabine Review and Zalcitabine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

5803000-X | Abortion Spontaneous
on Jun 27, 2008 Female patient from UNITED STATES , 30 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Invirase (View Usage). Patient had the following side effects: abortion spontaneous. Invirase dosage: . During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), FORTOVASE (View Fortovase Review and Fortovase Label ), COMBIVIR (View Combivir Review and Combivir Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

5757308-7 | Erythema, Testicular Pain
Patient was taking Invirase (View Usage). After Invirase was administered, patient had the following side effects: erythema, testicular pain on May 22, 2008 from MEXICO Additional patient health information: Male patient , weighting 143.3 lb, . Invirase dosage: Four Dose Forms Daily. During the same period patient was treated with RITONAVIR (Two Dose Forms Daily) (View Ritonavir Review and Ritonavir Label ), TRUVADA (Strength: Tenofovir/emtricitabine, 300/200 Mg. One Dose Form Daily.) (View Truvada Review and Truvada Label ).

5702135-X | Cellulitis, Diabetes Mellitus, Hypothyroidism, Lipodystrophy Acquired, Myocardial Infarction, Weight Increased
Adverse event was reported on Apr 02, 2008 by a Male patient taking Invirase (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED STATES , weighting 283.1 lb, Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), diabetes mellitus, hypothyroidism, lipodystrophy acquired, myocardial infarction, weight increased. During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), ATENOLOL (Frequency Reported As 'pid') (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

5700034-0 | Colitis Ulcerative
on Mar 31, 2008 Male patient from MEXICO , 41 years of age, weighting 116.8 lb, was treated with Invirase (View Usage). Patient had the following side effects: colitis ulcerative. Invirase dosage: Dosage Regimen Reported As 4 Qd.. During the same period patient was treated with RITONAVIR (Dosage Regimen: 2 Qd.) (View Ritonavir Review and Ritonavir Label ), LAMIVUDINE + ZIDOVUDINE (Dose: 2 Qd. Strength: Lamivudine/zidovudine: 150+250mg =400 Mg) (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ), RANITIDINE (Dosage Regimen: 2 Qd.) (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

5685033-X | Lactic Acidosis
on Jul 21, 1998 Female patient from ITALY , 53 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Invirase (View Usage). After Invirase was administered, patient had the following side effects: lactic acidosis. Invirase dosage: . During the same period patient was treated with ZERIT (View Zerit Review and Zerit Label ), EPIVIR (View Epivir Review and Epivir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LASIX (View Lasix Review and Lasix Label ).

5653611-X | Anorexia, Arthralgia, Asthenia, Bone Pain, Dysgeusia, Pruritus, Renal Failure Acute, Urticaria, Vomiting
Patient was taking Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, arthralgia, asthenia, bone pain, dysgeusia, pruritus, renal failure acute, urticaria, vomiting on Feb 25, 2008 from FRANCE Additional patient health information: Female patient , 72 years of age, . Invirase dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), ISOPTINE LP (View Isoptine Lp Review and Isoptine Lp Label ), COTAREG (Strength: 160 Mg/25mg. One Dose Per Day) (View Cotareg Review and Cotareg Label ), MOCLAMINE (View Moclamine Review and Moclamine Label ). Patient was hospitalized.

5646748-2 | Arteriovenous Malformation, Patent Ductus Arteriosus, Pregnancy, Trisomy 21
Adverse event was reported on Feb 13, 2008 by a Female patient taking Invirase (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 3.97 lb, Patient had the following side effects: arteriovenous malformation (What is arteriovenous malformation?), patent ductus arteriosus, pregnancy (What is pregnancy?), trisomy 21. During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), COMBIVIR (View Combivir Review and Combivir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METRONIDAZOLE HCL (View Metronidazole Hcl Review and Metronidazole Hcl Label ), ZANTAC 150 (View Zantac 150 Review and Zantac 150 Label ).

5636890-4 | Optic Neuritis Retrobulbar
on Feb 13, 2008 Male patient from FRANCE , 52 years of age, was treated with Invirase (View Usage). After Invirase was administered, patient had the following side effects: optic neuritis retrobulbar. Invirase dosage: Reported Dosing Amount: 4 Doses Daily.. During the same period patient was treated with BACTRIM (Also Received On 28 September 2005 And 23 June 2006.) (View Bactrim Review and Bactrim Label ), COMBIVIR (Reported Dosing Amount: 2 Doses Daily.) (View Combivir Review and Combivir Label ), TELZIR (Reported Dosing Amount: 2 Doses Daily. Also Received On 17 June 2005.) (View Telzir Review and Telzir Label ), NORVIR (Also Received On 15 October 2004, 29 March 2005, 28 September 2005, 17 June 2005 And 23 June 2006.) (View Norvir Review and Norvir Label ). Patient was hospitalized and became disabled.

5632219-6 | Arteriovenous Malformation, Patent Ductus Arteriosus, Pregnancy, Trisomy 21
on Feb 05, 2008 Female patient from UNITED STATES , weighting 3.97 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: arteriovenous malformation (What is arteriovenous malformation?), patent ductus arteriosus, pregnancy (What is pregnancy?), trisomy 21. Invirase dosage: . During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), COMBIVIR (View Combivir Review and Combivir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

5629620-3 | Atrioventricular Septal Defect, Patent Ductus Arteriosus, Trisomy 21
Patient was taking Invirase (View Usage). Patient had the following side effects: atrioventricular septal defect, patent ductus arteriosus, trisomy 21 on Feb 08, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 4.41 lb, . Invirase dosage: ^2000^. During the same period patient was treated with NORVIR (^200^ Is The Reported Daily Dose) (View Norvir Review and Norvir Label ), VIRACEPT (^2500^ Is The Reported Daily Dose) (View Viracept Review and Viracept Label ), COMBIVIR (^900^ Is Reported Today Daily Dose) (View Combivir Review and Combivir Label ), SUPPLEMENT NOS (Reported As Folate Supplement, Taken During The First And Second Trimesters.) (View Supplement Nos Review and Supplement Nos Label ), METRONIDAZOLE HCL (Took During Her Third Trimester.) (View Metronidazole Hcl Review and Metronidazole Hcl Label ), ZANTAC (Taken During Her Second Trimester.) (View Zantac Review and Zantac Label ), PRENATAL (Reported As Prenatal Tabs Taken During Her Second And Third Trimesters.) (View Prenatal Review and Prenatal Label ).

5625883-9 | Atrioventricular Septal Defect, Patent Ductus Arteriosus, Trisomy 21
Adverse event was reported on Feb 05, 2008 by a Female patient taking Invirase (View Usage) (Dosage: ^2000^) . Location: UNITED STATES , weighting 4.41 lb, After Invirase was administered, patient had the following side effects: atrioventricular septal defect, patent ductus arteriosus, trisomy 21. During the same period patient was treated with NORVIR (^200^ Is The Reported Daily Dose) (View Norvir Review and Norvir Label ), VIRACEPT (^2500^ Is The Reported Daily Dose) (View Viracept Review and Viracept Label ), COMBIVIR (^900^ Is Reported Today Daily Dose) (View Combivir Review and Combivir Label ).

5597548-3 | Benign Neoplasm
on Jan 09, 2008 Male patient from MEXICO , 22 years of age, weighting 149.9 lb, was treated with Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: benign neoplasm. Invirase dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

5585348-X | Multi-organ Failure, Pseudomonal Bacteraemia, Sepsis Syndrome, Septic Shock
on Jan 02, 2008 Male patient from UNITED STATES , 42 years of age, weighting 92.59 lb, was treated with Invirase (View Usage). Patient had the following side effects: multi-organ failure, pseudomonal bacteraemia, sepsis syndrome, septic shock. Invirase dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ). Patient was hospitalized.

5566618-8 | Electrocardiogram Qt Prolonged
Patient was taking Invirase (View Usage). After Invirase was administered, patient had the following side effects: electrocardiogram qt prolonged on Dec 07, 2007 from SWITZERLAND Additional patient health information: Female patient , 59 years of age, . Invirase dosage: . During the same period patient was treated with CIPROFLOX (Form: Film Coated Tablets) (View Ciproflox Review and Ciproflox Label ), KALETRA (View Kaletra Review and Kaletra Label ), DILZEM (View Dilzem Review and Dilzem Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), FLAGYL (View Flagyl Review and Flagyl Label ), NEXIUM (View Nexium Review and Nexium Label ).

5529298-3 | Diabetes Mellitus, Hypothyroidism, Lipodystrophy Acquired, Myocardial Infarction, Weight Increased
Adverse event was reported on Nov 20, 2007 by a Male patient taking Invirase (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED STATES , 53 years of age, weighting 283.1 lb, Patient experienced the following unwanted or unexpected effects: diabetes mellitus, hypothyroidism, lipodystrophy acquired, myocardial infarction, weight increased. During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), ATENOLOL (Frequency Reported As 'pid') (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FELODIPINE (View Felodipine Review and Felodipine Label ).

5511438-3 | Pseudomonas Infection, Sepsis Syndrome
on Oct 31, 2007 Male patient from UNITED STATES , 42 years of age, was treated with Invirase (View Usage). Patient had the following side effects: pseudomonas infection, sepsis syndrome. Invirase dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ). Patient was hospitalized.

5490867-0 | Complication Of Pregnancy
on Oct 08, 2007 Female patient from UNITED STATES , 23 years of age, was diagnosed with acute hiv infection (What is acute hiv infection?) and was treated with Invirase (View Usage). After Invirase was administered, patient had the following side effects: complication of pregnancy. Invirase dosage: Total Daily Dose: 600mg/300mg. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

5488438-5 | Congenital Toxoplasmosis
Patient was taking Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: congenital toxoplasmosis on Oct 08, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 5.73 lb, was diagnosed with hiv infection (What is hiv infection?) and. Invirase dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), KALETRA (View Kaletra Review and Kaletra Label ), AZT (View Azt Review and Azt Label ).

5485723-8 | Optic Neuritis Retrobulbar
Adverse event was reported on Oct 02, 2007 by a Male patient taking Invirase (View Usage) (Dosage: Reported Dosing Amount: 4 Doses Daily.) . Location: FRANCE , 52 years of age, Patient had the following side effects: optic neuritis retrobulbar. During the same period patient was treated with BACTRIM DS (Also Received On 28 September 2005 And 23 June 2006.) (View Bactrim Ds Review and Bactrim Ds Label ), COMBIVIR (Reported Dosing Amount: 2 Doses Daily.) (View Combivir Review and Combivir Label ), TELZIR (Reported Dosing Amount: 2 Doses Daily. Also Received On 17 June 2005.) (View Telzir Review and Telzir Label ), NORVIR (Also Received On 15 October 2004, 29 March 2005, 28 September 2005, 17 June 2005 And 23 June 2006.) (View Norvir Review and Norvir Label ).

5480347-0 | Coronary Artery Disease
on Sep 28, 2007 Male patient from FRANCE , 46 years of age, weighting 132.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Invirase (View Usage). After Invirase was administered, patient had the following side effects: coronary artery disease (What is coronary artery disease?). Invirase dosage: . During the same period patient was treated with TRIZIVIR (View Trizivir Review and Trizivir Label ), KALETRA (View Kaletra Review and Kaletra Label ), COMBIVIR (View Combivir Review and Combivir Label ), ZERIT (View Zerit Review and Zerit Label ), NORVIR (View Norvir Review and Norvir Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ).

5476003-5 | Abortion Spontaneous
on Sep 24, 2007 Female patient from FINLAND , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Invirase (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Invirase dosage: Frequency Reported As 2x2. During the same period patient was treated with VIRACEPT (Frequency Reported As 5x2) (View Viracept Review and Viracept Label ), NORVIR (Frequency Reported As 1x2) (View Norvir Review and Norvir Label ), COMBIVIR (Frequency Reported As 1x2) (View Combivir Review and Combivir Label ). Patient was hospitalized.

5426299-0 | Caesarean Section, Klinefelter's Syndrome
Patient was taking Invirase (View Usage). Patient had the following side effects: caesarean section, klinefelter's syndrome on Aug 16, 2007 from SWITZERLAND Additional patient health information: Male patient , weighting 6.61 lb, was diagnosed with hiv infection (What is hiv infection?) and. Invirase dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), COMBIVIR (View Combivir Review and Combivir Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).